The Pathogenesis and Prognostic Factors of Lymphoma

The Pathogenesis and Prognostic Factors of Lymphoma

The aim of this study is to describe the clinical and genetic characteristics of Chinese lymphoma patients, and to explore the relationship between those characteristics and phatogenesis.

Lymphoma is a highly common malignant tumor in Asia. This study aims to observe and describe the clinical and genetic charateristics of Chinese lymphoma patients, and to explore the relationship between those charateristics and pathogenesis and prognostic factors in the real-world population. This study is a non-interventional real world, observational study and all registered data are collected from real clinical practice cases. The medical data includes patient demographic, tumor characteristics, laboratory examination, history of treatments, adverse reactions, efficacy results and possible prognostic factors.

Inclusion Criteria:

• Patients with pathological diagnosis of lymphoma (including Hodgkin lymphoma and non-Hodgkin lyphoma, eg. THRLBCL, DLBCL, MZL, CLL/SLL...) from 2007 to 2027.
• Patients with complete diagnostic, treatment and follow-up records.
• Fully comprehension and signature of the informed consent form (ICF) for participation.

Exclusion Criteria:

• Those who refuse to use reliable methods of contraception during pregnancy, lactation or age-appropriate period.
• Severe mental illness.
• Patients deemed unsuitable for inclusion by the investigator.